These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


241 related items for PubMed ID: 38053199

  • 21. [Refractory eosinophilic gastroenteritis with gastritis, duodenal ulcer, and colitis: a case report].
    Miura Y, Iwamoto F, Ishida Y, Kuno T, Tanaka K, Kobayashi S, Yoshida T, Yamaguchi T, Sato T, Enomoto N.
    Nihon Shokakibyo Gakkai Zasshi; 2019; 116(8):668-675. PubMed ID: 31406072
    [Abstract] [Full Text] [Related]

  • 22. Dupilumab Can Induce Remission of Eosinophilic Gastritis and Duodenitis: A Retrospective Case Series.
    Sia T, Bacchus L, Tanaka R, Khuda R, Mallik S, Leung J.
    Clin Transl Gastroenterol; 2024 Jan 01; 15(1):e00646. PubMed ID: 37753954
    [Abstract] [Full Text] [Related]

  • 23. Real World Experience With Dupilumab in Eosinophilic Esophagitis in Children and Young Adults at a Tertiary Care Pediatric Medical Center.
    Syverson EP, Rubinstein E.
    JPGN Rep; 2022 May 01; 3(2):e180. PubMed ID: 37168913
    [Abstract] [Full Text] [Related]

  • 24. Benralizumab treatment in an elderly patient with eosinophilic esophagitis resulted in remission: a case report.
    Ishii A, Shibata T, Tsunoda Y, Kayukawa T, Kobayashi M, Orinaka M, Miyamatsu S, Ryuge Y, Asano S, Tanaka I.
    BMC Geriatr; 2024 Jan 24; 24(1):92. PubMed ID: 38267847
    [Abstract] [Full Text] [Related]

  • 25. Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis.
    Wechsler ME, Klion AD, Paggiaro P, Nair P, Staumont-Salle D, Radwan A, Johnson RR, Kapoor U, Khokhar FA, Daizadeh N, Chen Z, Laws E, Ortiz B, Jacob-Nara JA, Mannent LP, Rowe PJ, Deniz Y.
    J Allergy Clin Immunol Pract; 2022 Oct 24; 10(10):2695-2709. PubMed ID: 35636689
    [Abstract] [Full Text] [Related]

  • 26. Improvement in eosinophilic esophagitis when using dupilumab for other indications or compassionate use.
    Spergel BL, Ruffner MA, Godwin BC, Liacouras CA, Cianferoni A, Gober L, Hill DA, Brown-Whitehorn TF, Chaiboonma K, Aceves SA, Muir AM, Spergel JM.
    Ann Allergy Asthma Immunol; 2022 May 24; 128(5):589-593. PubMed ID: 35085819
    [Abstract] [Full Text] [Related]

  • 27. Current state of biologics in treating eosinophilic esophagitis.
    Nhu QM, Aceves SS.
    Ann Allergy Asthma Immunol; 2023 Jan 24; 130(1):15-20. PubMed ID: 36243282
    [Abstract] [Full Text] [Related]

  • 28. Disease Course and Treatment Response of Eosinophilic Gastrointestinal Diseases in Children With Liver Transplantation: Long-Term Follow-Up.
    Ozdogan E, Doganay L, Can D, Arikan C.
    Am J Gastroenterol; 2021 Jan 01; 116(1):188-197. PubMed ID: 33065587
    [Abstract] [Full Text] [Related]

  • 29. Efficacy and safety of dupilumab up to 52 weeks in adults and adolescents with eosinophilic oesophagitis (LIBERTY EoE TREET study): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
    Rothenberg ME, Dellon ES, Collins MH, Hirano I, Chehade M, Bredenoord AJ, Lucendo AJ, Spergel JM, Sun X, Hamilton JD, Mortensen E, Laws E, Maloney J, Mannent LP, McCann E, Liu X, Glotfelty L, Shabbir A.
    Lancet Gastroenterol Hepatol; 2023 Nov 01; 8(11):990-1004. PubMed ID: 37660704
    [Abstract] [Full Text] [Related]

  • 30. Scientific journey to the first FDA-approved drug for eosinophilic esophagitis.
    Rothenberg ME.
    J Allergy Clin Immunol; 2022 Dec 01; 150(6):1325-1332. PubMed ID: 36209816
    [Abstract] [Full Text] [Related]

  • 31. [Eosinophilic esophagitis in children: analysis of 22 cases].
    Sun MF, Gu WZ, Peng KR, Liu MN, Shu XL, Jiang LQ, Jiang MZ.
    Zhonghua Er Ke Za Zhi; 2017 Jul 02; 55(7):499-503. PubMed ID: 28728257
    [Abstract] [Full Text] [Related]

  • 32. Utility of gastric and duodenal biopsy sampling in adult eosinophilic esophagitis patients to rule out other gastrointestinal disorders.
    de Rooij WE, Haasnoot ML, Lei A, Warners MJ, Mookhoek A, Bredenoord AJ.
    Scand J Gastroenterol; 2021 May 02; 56(5):613-620. PubMed ID: 33835892
    [Abstract] [Full Text] [Related]

  • 33. Eosinophilic Gastritis/Gastroenteritis.
    Chen PH, Anderson L, Zhang K, Weiss GA.
    Curr Gastroenterol Rep; 2021 Jul 30; 23(8):13. PubMed ID: 34331146
    [Abstract] [Full Text] [Related]

  • 34. Eosinophilic Esophagitis Patients Are Not at Increased Risk of Severe COVID-19: A Report From a Global Registry.
    Zevit N, Chehade M, Leung J, Marderfeld L, Dellon ES.
    J Allergy Clin Immunol Pract; 2022 Jan 30; 10(1):143-149.e9. PubMed ID: 34688963
    [Abstract] [Full Text] [Related]

  • 35. The efficacy of dupilumab in induction and maintenance of remission in an adult patient with steroid-dependent eosinophilic enteritis (EoN).
    Watanabe S, Uchida H, Fujii R, Uga M, Machida T, Matsukawa N, Kurihara M, Negi M, Yauchi T.
    Clin J Gastroenterol; 2023 Aug 30; 16(4):527-531. PubMed ID: 37038042
    [Abstract] [Full Text] [Related]

  • 36. [Recent progress in the research of Eosinophilic GastroIntestinal Diseases (EGIDs)].
    Mishiro T, Ishimura N, Ishihara S, Kinoshita Y.
    Nihon Yakurigaku Zasshi; 2018 Aug 30; 152(4):175-180. PubMed ID: 30298838
    [Abstract] [Full Text] [Related]

  • 37. Eosinophil infiltration in the upper gastrointestinal tract of patients with bronchial asthma.
    Imaeda H, Yamaoka M, Ohgo H, Yoneno K, Kobayashi T, Noguchi T, Uchida Y, Soma T, Kayano H, Kanazawa M, Nakamoto H, Nagata M.
    Allergol Int; 2016 Sep 30; 65 Suppl():S6-S10. PubMed ID: 27118436
    [Abstract] [Full Text] [Related]

  • 38. Early life exposures as risk factors for non-esophageal eosinophilic gastrointestinal diseases.
    Jensen ET, Dai X, Kodroff E, Strobel MJ, Zicarelli A, Gray S, Cordell A, Anderson C, Hiremath G, Dellon ES.
    Clin Res Hepatol Gastroenterol; 2023 Aug 30; 47(7):102170. PubMed ID: 37352927
    [Abstract] [Full Text] [Related]

  • 39. Relapse of Eosinophilic Esophagitis on Dupilumab.
    Buendia MA, Choksi YA, Hiremath G.
    JPGN Rep; 2022 Nov 30; 3(4):e273. PubMed ID: 37168482
    [Abstract] [Full Text] [Related]

  • 40. Association Between Endoscopic and Histologic Findings in a Multicenter Retrospective Cohort of Patients with Non-esophageal Eosinophilic Gastrointestinal Disorders.
    Pesek RD, Reed CC, Collins MH, Muir AB, Fulkerson PC, Menard-Katcher C, Falk GW, Kuhl J, Magier AZ, Ahmed FN, Demarshall M, Gupta A, Gross J, Ashorobi T, Carpenter CL, Krischer JP, Gonsalves N, Hirano I, Spergel JM, Gupta SK, Furuta GT, Rothenberg ME, Dellon ES, Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR).
    Dig Dis Sci; 2020 Jul 30; 65(7):2024-2035. PubMed ID: 31773359
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 13.